EPA vs. DHA: Why the Omega-3 Ratio Matters and Which to Prioritize for Your Goal

Updated: June 2026EPA · DHA · omega-3 ratio · REDUCE-IT · triglycerides · fish oil quality
25%
Reduction in cardiovascular events with high-dose EPA (4g/day) in REDUCE-IT trial (n=8,179)
45%
Triglyceride reduction with 4g/day omega-3 (prescription icosapentaenoic acid) — dose-dependent effect
2:1
EPA:DHA ratio for inflammation and cardiovascular goals; 1:2 DHA:EPA for cognitive and depression focus
TOTOX
The oxidation marker to check on supplement labels — below 26 is fresh; above 26 means rancid fish oil

Most people who take fish oil supplements buy a generic capsule without considering whether the omega-3 content is primarily EPA, DHA, or a combination — and at what dose. This matters because EPA and DHA have fundamentally different biological mechanisms. They're both omega-3 fatty acids, but they operate on different targets and have different strongest evidence bases. Taking a 500mg "omega-3 supplement" that's mostly DHA for cardiovascular protection is like taking the wrong medication.

EPA (Eicosapentaenoic Acid)

  • Primary mechanism: anti-inflammatory eicosanoid production
  • Competes with arachidonic acid to produce less inflammatory prostaglandins
  • Strongest evidence: cardiovascular protection, triglyceride reduction
  • REDUCE-IT: 4g/day EPA reduced MACE 25% in high TG patients
  • Also: depression (meta-analyses favor EPA over DHA for mood)
  • Less DHA accumulates in brain vs. EPA — EPA doesn't drive brain structural changes

DHA (Docosahexaenoic Acid)

  • Primary mechanism: structural phospholipid in neural and retinal membranes
  • 60% of brain's polyunsaturated fatty acids are DHA
  • Strongest evidence: fetal brain development, infant cognition
  • Also: cognitive aging, retinal health, adult neuroplasticity
  • Algae oil is DHA-rich (vegan source) — EPA content in algae is lower
  • Critical in pregnancy and for infants; less so for general adult cardiovascular health
REDUCE-IT Trial — High-Dose EPA for Cardiovascular Risk

4g/day pure EPA reduced MACE by 25% in statin-treated patients with elevated triglycerides

n=8,179, statin-treated patients with elevated triglycerides (135–499 mg/dL) and established cardiovascular disease or diabetes + risk factors. Mean 4.9 years.

Vascepa (icosapentaenoic acid — pure EPA, no DHA) at 4g/day reduced 3-point MACE by 25% and cardiovascular death by 20% vs. mineral oil placebo. The triglyceride reduction alone (~20%) does not explain the cardiovascular benefit magnitude, suggesting direct plaque-stabilizing and anti-inflammatory effects of EPA. This trial produced the only prescription omega-3 product (Vascepa) approved by the FDA for cardiovascular risk reduction.

The STRENGTH trial counterpoint: STRENGTH used a high-dose EPA+DHA combination (omega-3 carboxylic acids) and showed no cardiovascular benefit vs. corn oil. This suggests the EPA-specific mechanism — not omega-3s in general — drives the REDUCE-IT result. The EPA:DHA ratio and purity appear to matter for cardiovascular outcomes.

High-dose EPA → MACE reductionStrong · REDUCE-IT RCT, n=8,179
Omega-3 → Triglyceride reductionVery Strong · Consistent across trials
DHA → Cognitive protection agingModerate · Observational + small RCTs
Want the full evidence writeup?
The Stack Protocol builds four complete goal stacks — Energy, Focus, Sleep, Longevity — with exact doses, timing, budget tiers, and a 30-day rollout plan, graded with the same evidence framework behind this page.
Get the Stack Protocol → $19

Dosing by goal

GoalRecommended FormTarget Daily DoseNotes
Cardiovascular protection (high TG)High-EPA fish oil or prescription Vascepa2–4g EPA/dayRx Vascepa required for 4g; OTC high-EPA oils at 2g may provide partial benefit
General cardiovascular + anti-inflammatoryBalanced EPA+DHA fish oil (2:1 EPA:DHA)1–2g combined EPA+DHAStandard recommendation; minimum effective dose
Depression / mood supportEPA-dominant (≥60% EPA)1–2g EPA/dayMeta-analyses: EPA more effective than DHA for depression; minimum 60% EPA ratio
Brain health / cognitive agingDHA-dominant or balanced500mg–1g DHA/dayDHA is the structural brain fatty acid; EPA also contributes
Pregnancy / infantDHA-dominant prenatal omega-3200–300mg DHA/day (WHO minimum)Critical for fetal brain development; most prenatal vitamins contain inadequate DHA
Vegan / vegetarianAlgae oil (DHA-dominant)250–500mg DHA + some EPAAlgae is the original source — fish get DHA from eating algae
Fish Oil Quality — The Oxidation Problem

Omega-3 fatty acids are highly unsaturated and oxidize rapidly — rancid fish oil produces aldehydes and lipid peroxides that may negate cardiovascular benefits and cause harm. Key quality markers:

TOTOX (total oxidation) score: Should be below 26; below 10 is excellent. Few brands publish this; request a certificate of analysis or choose brands that voluntarily disclose.

IFOS certification: International Fish Oil Standards certification verifies purity, oxidation levels, and heavy metal testing. A reliable quality proxy when TOTOX data isn't available.

Smell test: Fresh fish oil should not smell strongly fishy. Strong, offensive fish odor indicates significant oxidation. If your capsules smell bad after cutting them open, throw them out.

Storage: Refrigerate after opening. Keep away from light and heat. Replace every 90 days once opened.

High-EPA Fish Oil → Algae Oil (Vegan) → IFOS-Certified Oil →

Cardiovascular and inflammation stack

Omega-3 Complete Guide → D3/K2 → CoQ10 → GLP-1 Heart Benefits →

As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.